Disruption is a pressing problem in the pharmaceutical world; patient health depends on clinical trial organisers avoiding it ...
The FDA announced new provisions that require sponsors to submit Diversity Action Plans. But what does that mean for the ...
The FDA mandate to increase diversity in clinical trials fails to address critical issues in treatment for Black women, ...
BioDuro-Sundia opens new kilogram laboratory at Shanghai to speed development from discovery to preclincal and clinical ...
The rising prevalence of urticaria is fueling market growth, with increased allergic responses and lifestyle shifts playing key roles. Advances in biologic treatments and a strong development pipeline ...
Europe has been falling behind on clinical trials over the past decade as pharmaceutical companies shift their focus to the ...
Palleos Healthcare has a distinguished history of advancing medical innovations, leveraging its extensive experience and network to accelerate the development of new therapies. By integrating academic ...
As the pharmaceutical industry rapidly transforms, companies seeking to achieve and hold the leading positions on the market ...
Innovative products, such as those being developed by DELFI, will aid in the efficient progress of those medicines through the clinic," said Susan Macdonald, PhD, SVP Nonclinical Development & ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback